Transderma Pharmaceuticals Inc. was founded by Pharmacists in collaboration with pharmaceutical formulation experts with a commitment to discover and manufacture topical delivery systems to address the growing need for effective trans -cellular drug delivery.
Transdema launched its pre-mixed Premium Lecithin Organogel Base (PLO Gel) along with its range on PLO Kits in 2000.
Subsequent product development has resulted in the production of a number of topical bases for various compounding applications.
Transderma adheres to high GMP manufacturing standards in order to create consistent, high-quality products with superior efficacy and safety profiles.
Transderma remains committed to the development of pharmaceutically elegant, quality products that enhance the practice of pharmaceutical compounding.
Trusted Advanced-Technology combined with High-Quality Ingredients yields Superior Products.
Transderma adheres to high cGMP manufacturing standards in order to create consistent, high-quality products with superior efficacy and safety profiles. Specially selected ingredients are used for the prevention of microbiological or fungal contamination, while refined- oils maximize delivery potential of active ingredients. In particular, the PLO product line combines the delivery intelligence of traditional lecithin organogels yet maintains the cosmetic appeal of an elegant, yet effective, robust transdermal gel.
Transderma also offers a wide variety of other vehicles for professional compounding needs.